Tamoxifen
| CAS No. | 10540-29-1 |
|---|---|
| MDL No. | MFCD00010454 |
| MF | C26H29NO |
| MW | 371.50 |
| InChI Key | NKANXQFJJICGDU-QPLCGJKRSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Tamoxifen is a tertiary amino compound and a stilbenoid derived from a stilbene hydride. It functions as an estrogen receptor antagonist, modulator, and antagonist, an angiogenesis inhibitor, an EC 2.7.11.13 (protein kinase C) inhibitor, an EC 1.2.3.1 (aldehyde oxidase) inhibitor, and an antineoplastic agent, as well as a bone density conservation agent.
| CAS No. | 10540-29-1 |
|---|---|
| Product Name | Tamoxifen |
Biological Targets
ESR1
Associated Conditions
breast ductal carcinoma in situ·urinary bladder cancer·menopause·breast cancer·Desmoid-type fibromatosis·
* The information provided here is compiled from public sources and is for reference only.
